🫁FREE MSRA PODCAST –Malignant Mesothelioma 🔬
A concise yet comprehensive overview of one of thetoughest respiratory cancers — with a direct link to asbestos exposure
This episode tacklesthe diagnostic red flags, clinical pathway, and management principles for mesothelioma. Perfect for MSRA prep orclinical revision.
🧠Key Learning Points
📌Definition
• Malignant mesothelioma is a rare, aggressivecancer of the mesothelial lining
• Most commonlyaffects the pleura (lungs), but alsoperitoneum, pericardium, testicles
📌Causes
☠️ Strongly linked to asbestos exposure (industrial settings like shipyards, construction)
⏱️ Long latency: symptoms often occur 20–40 years after exposure
📌Pathophysiology
• Asbestos fibres embed in mesothelium → chronicinflammation → DNA damage
• Leads to uncontrolled cell growth, local invasion, andpleural thickening
• Distant metastasisis uncommon, but local invasion is significant
📌Epidemiology
📈 UK incidence: ~2,700 cases/year
👨 Affects older males disproportionately (due tooccupational exposure)
📊 10-year survival in the UK: ~2%
📌Symptoms
• Pleural type (most common): 🫁 Chest pain, dyspnoea, persistent cough, pleural effusion
• 🧍 Weight loss, fatigue, finger clubbing
• Peritoneal type: abdominal swelling, pain,altered bowel habit
• Early symptomsoften vague → late diagnosis common
📌Examination &Clues
• ↓ breath sounds, ↓chest expansion, dullness to percussion (effusion)
• Pleural fluid: maybe straw-coloured or blood-stained
• Clubbing,performance status, asbestos exposure history
📌Diagnosis
🖼️ Imaging: chest X-ray → CT scan → PET/MRI forstaging
💉 Pleural aspiration → low cytology yield (~30%)
🔍 Definitive: biopsy (VATS orimage-guided) with immunohistochemistry
🧪 Lung function tests if surgery considered
📌Staging
• Uses TNM classification
• Stage I: localisedto pleura
• Stage IV: spreadto contralateral chest or distant organs
📌Management
🩹Palliative care is often central due to late diagnosis and poorprognosis
💊Chemotherapy (cisplatin/carboplatin + pemetrexed) = first-line
🔪Surgery (for select early-stage cases only):
• EPP – Extrapleural pneumonectomy (lung + pleura+ diaphragm)
• PD – Pleurectomy/decortication (removes tumour,spares lung)
☢️ Radiotherapy: limited role, used for pain or proceduraltract prophylaxis
💧 Recurrent effusions: drainage + pleurodesis (e.g., talc)
📌Prognosis
📉 Median survival = 6 to 18 months
🧬 Better in: early-stage, peritoneal type,epithelial subtype, good performance status
📌Complications
• Respiratoryfailure
• Recurringeffusions
• Chest wall pain
• Infection,cachexia, multi-organ dysfunction
• Side effects fromchemo/surgery
➡️ Palliative symptom control is crucial
📎More MSRA Resourceson Mesothelioma:
📝 Revision Notes: https://www.passthemsra.com/topic/malignant-mesothelioma-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/malignant-mesothelioma-flashcards/
💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/malignant-mesothelioma-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/malignant-mesothelioma-rapid-quiz/
🎓 Full Respiratory Course: https://www.passthemsra.com/courses/respiratory-for-the-msra/
Hashtags
#MSRA #MSRARevision#MesotheliomaMSRA #RespiratoryMSRA #MSRAFlashcards #MSRAQuiz #MSRAAccordions#MSRAStudyMaterials #NICEGuidelines #MedicalEducation #MSRAOnlineRevision#MultiSpecialityRecruitmentAssessment